Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to Ophthalmology Times Europe.
Click here to unsubscribe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
• B + L acquire Technolas
• Rudin Glaucoma Prize awarded
• Axial length affects RNFL
• Anti-VEGF monotherapy for SRNVM
 
 
Survey

Would you use anti-VEGF monothearpy for SRNVM secondary to Mactel?

Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.
November 21, 2012
Bausch + Lomb acquire Technolas Perfect Vision
Bausch + Lomb will purchase all outstanding shares of leading ophthalmic laser company Technolas Perfect Vision. More...
Rudin Glaucoma Prize winner announced
Dr Daniel Stamer has been awarded the prestigious Lewis Rudin Glaucoma Prize 2012. More...
Product Profile
OertliKatalyst— NanoTapered tip design
Oertli Instruments, based in Berneck Switzerland, has launched a series of micro-instruments featuring NanoTapered tip design. Read More:
Axial length affects RNFL thickness profiles
Axial length/refractive status affects the peripapillary retinal nerve fibre layer (RNFL) thickness profile in eyes measured by RTVue OCT. More...
Anti–VEGF monotherapy safe and effective for SRNVM
Intravitreal anti-VEGF monotherapy is safe and effective in treatment-naïve subretinal neovascular membrane (SRNVM) secondary to macular telangiectasia (Mactel). More...